Malignant melanomas are often infiltrated by T lymphocytes. It is postulated that the presence of tumor-infiltrating lymphocytes (TIL) reflects ongoing immune responses against transformed cells. Such "responses" appear generally inefficient with the potential exception of unfrequent clinical situations characterized by spontaneous tumor regression. We have characterized here the molecular structure of the T cell receptor 0 chain expressed by TILs in a case of regressive melanoma. Advantage was taken of the PCR technology to study T lymphocytes directly without cell culture. Experimentally validated VfI subfamily specific primers were used to evaluate the V# usage in TILs and control samples. Our results reveal that clonal T cell populations, precisely defined by their V-D-J junctional sequences, are amplified at the tumor site. The existence of such local antigen-driven selections support the hypothesis that antitumor responses may indeed take place in regressive melanoma. (J. Clin. Invest. 1993Invest. . 91:1183Invest. -1190 
Introduction
Melanoma is a human cancer where the immune system is thought to play an important role in the control of malignant cell growth. Many in vitro studies have shown the existence of specific immune interactions: cultured T cells derived either from PBL, lymph node, or the site of the tumor were found to display specific MHC-restricted regulatory or effector activities in response to autologous melanoma cells (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Encouraging results have been obtained with ex vivo expanded tumor-infiltrating lymphocytes (TIL)' in the presence of IL-2 for the treatment of solid tumors in both animal models ( 11) and human metastatic melanomas ( 12, 13) . In addition, it is well established that spontaneous regressions (14) (15) (16) (17) , either partial or complete, occur more frequently in melanoma than in other malignant diseases ( 14, 18, 19) . Such regressions correlate with a high degree oftumor lymphoid infiltration and may well result from an efficient physiological immune response ( 16) . Thus, spontaneously regressing melanoma represents a model of interest to study potential in vivo antitumor responses.
Lymphocytes infiltrating melanoma lesions are mostly CD3+ a /f T lymphocytes (20, 21 ) . It is known that mature a/fI T cells specifically recognize antigenic peptides presented by MHC molecules through their heterodimeric surface receptor (TCR) which associates the a and f polypeptides (22) . The specific recognition is dependent upon interaction between MHC/peptide complex and the variable region of TCR molecules. During T cell differentiation, unique variable region genes are created by recombination of variable (V), diversity (D) and joining (J) segments for the d locus, and of V and J segments for the a locus. The joining ofa random combination of these segments, as well as the pairing of the two chains, generates combinatorial diversity which is greatly increased by imprecise V-D-J (for the : locus) or V-J (for the a locus) joinings (junctional flexibility) and the addition of N-region nucleotides (23) . Thus, the expression of unique rearranged TCR gene products determines the specificity of a given T cell.
Since in vitro culture may select and amplify T cell subpopulations with minor representation in vivo, one way to study antitumor immune responses is to analyze directly the molecular structure ofTCR polypeptides expressed by TIL. The development of the PCR technology now allows us to perform such experiments. We have used here this method to characterize the local immune response in a case of spontaneously regressive melanoma. Our results show the presence of clonal T cell populations, precisely defined by their V-D-J-C junctional TCR sequences, at the tumor site. Such data strengthen the view that antigen-driven T cell selection may occur locally and contributes to the regression of the tumor.
Methods
Patient characteristics. The patient under study was a 65-yr-old woman suffering from a primary malignant melanoma of the leg, clinically surrounded by an inflammatory area. Histological examination of the tumor revealed the existence of a 4.5-mm thick pigmented mela- .. noma (24) with a Clark's level of III (25) composed by atypical globoid cells with high frequency of mitoses. Tumor cells were found to express the protein SI 00 and to be NSE positive (not shown). Numerous signs of active regression were present in the tumor (Fig. 1, A and B ) and the peritumoral inflammatory skin. Such typical morphologic characteristics of tumor regression ( 17, (26) (27) (28) included dense lymphocytic infiltrates among some degenerating melanoma cells, depigmented epidermis lacking a junctional component, pigmented melanophages revealed by Fontana's coloration, an increased number ofcapillaries, and foci of fibrosis. Samples and RNA. After surgical excision, fragments were obtained from tumor, inflammatory, and normal skin of the same patient. Samples were rapidly frozen in liquid nitrogen awaiting RNA extraction. Unstimulated autologous PBL were used as controls. Total RNA was prepared according to the guanidinium isothiocyanate-cesium chloride method (29) .
Immunohistochemical staining and mAbs. After surgical excision, a piece ofeach sample was immersed in isopentane, embedded in OCT compounds, and stored at -80'C until immunohistological staining. Slides were cleaned in 95% alcohol and subbedded in 0.3% gelatin solution containing 0.05% chromium potassium sulfate in distilled water. Cut frozen sections (4-Mm thick) were fixed for 10 min with cold acetone and stained with the first mAb. The immunohistological staining was performed using the alkaline phosphatase-anti-alkaline phosphatase complex method (30) .
To identify tumor cells, we used the Ep2 mAb (31), (HMW-MAA), that detects the high molecular weight melanoma-associated antigen expressed on a large percentage of human melanoma tumors (32) . The determinant recognized by Ep-2 mAb was strongly expressed on nearly all malignant cells ( Fig. 1 C) but no positive cells could be detected in the peritumoral inflammatory skin. T lymphocytes were studied using anti-CD2, anti-CD3, anti-CD4, and anti-CD8 mAbs (Becton Dickinson & Co., Mountain View, CA). To characterize the TCR, we used flF1 (T Cell Science Co., Cambridge, MA) which recognizes a nonpolymorphic epitope of the # chain expressed by all TCR a/f T cells, and TCRb I which reacts with a constant determinant of the TCR 6 chain (33) ofTCR y/ 6 T-cells (kindly provided by M. B. Brenner, Dana-Farber Institute, Boston, MA). PCR amplifications. First strand cDNA was synthetized from 5 4g of total RNA in a 50-MI final vol at 42°C for 1 h using AMV reverse transcriptase (Stratagene Inc., La Jolla, CA) and a specific CB region primer (5'-TATCTGGAGTCATTGAGGGCGGGC-3') .
To study the TCR V# repertoire, cDNA/RNA heteroduplex was then submitted to amplification by PCR (34) using a panel of VB-specific primers and the same Cfl-specific primer used for cDNA synthesis. The VB I -w24 oligonucleotides represent all the known V# subfamilies
and their specificity has been tested extensively (35) . Cfl-Cfl amplifications (190 bp) using a sense C#-specific primer (3'-CCCACCC-GAGGTCGCTGTGT-5') and the antisense Cfl-specific primer were performed as positive controls and to quantify the cDNA following Southern blot analysis. The same amount of specific cDNA from each sample was then used for further amplifications. Negative controls were performed without cDNA. 30 cycles of amplification were performed on a DNA Thermal Cycler (Perkin Elmer Cetus, Emeryville, CA) followed by a 15-min final extension at 72°C. Each cycle consisted of denaturation at 920C for 1 min, annealing at 600C for 1 min, and extension at 72°C for 1 min. All experiments were performed at least twice. The amplified products were detected by Southern blot analysis usingaCfl-specificoligonucleotideprobe( 5'-TCTGCTTCTGATGGC-TCAA-3').
Autoradiographs were scanned by quantitative densitometry with a dual wavelength chromato-scanner (CS 930; Shimadzu, Kyoto, Japan) providing an absolute value for each autoradiographic spot. Since amplification efficacy is known to vary from a primer pair to another ( 36) , these values did not reflect an absolute image of the repertoire really expressed. For this reason, each V: spot was expressed as a percentage of the sum of all Vfl signals detected on the autoradiogram. Since the same Vfl-C# primer pair was used in the different samples, intersample comparisons of a given amplified V gene segment could be performed.
For the cloning of V# 16 sequences, the primer were 5'-GCCTGCA-GAACTGGAGGATTCTGG-3' in the V region (position 279 from the ATG) and 5'-ACCAGCTCAGCTCCGCGGGGTCGG-3' in the Cfl region. This latter primer contains an artificial SacII cloning site.
The first strand cDNA/RNA heteroduplex was submitted to two rounds of 30 cycles of amplification (34) on a thermocycler (Hybaid, Teddington, UK). Each cycle consisted of 1 min at 940C, 1 min at 60'C, and 2 min at 720C. The last cycle was followed by a 10-min final extension at 720C. Between the two rounds of amplification, the material was size purified on a 1% low melting agarose gel. For the amplification of Vfl4 and V#19 sequences the primers were 5'-TTCCCATCAGCCGCCCAAACCTAA-3'forVfl4 region and 5'-TCC-TCTCACTGTGACATCGGCCCA-3' for V/319 region.
Cloning and sequencing of Vf316, V,34, and V#139 transcripts. After ethanol precipitation, half of the second amplification product was digested by SacII and then purified on a 2% agarose gel according to the Geneclean procedure (BIO 101, Inc., La Jolla, CA). The material was ligated into Bluescript SK+ (Stratagene Inc.) digested with SacII and EcoRV and used to transform XL 1-blue Escherichia coli strains (Stratagene Inc.). The white colonies were screened using a dot blot technique and a third nested Cfl 32P-labeled oligonucleotide (5'-TCTGCTTCTGATGGCTCAA-3') as a probe. Plasmid DNA was extracted from positive colonies and sequenced with Sequenase 2.0 (United States Biochemical Corp., Cleveland, OH) using the dideoxy chain termination procedure. Note, that to avoid artifacts, all the sequences for a given sample were obtained from at least two independent sets of amplifications and cloning procedure performed on at least two different cDNA.
Contamination. Particular attention was undertaken to avoid sample contamination. All solutions were aliquoted, and aliquots were used only once. Aside from the customary negative controls, a mock sample was processed along with each set ofexperimental samples during the entire procedure. This control was checked by hybridization with the C# probe (data not shown) and ruled out contamination at any step along the way.
Results
Immunohistochemical analysis ofmelanoma biopsies. Analysis of lymphocyte markers revealed that the tumor was infiltrated by numerous T lymphocytes, expressing the CD2 and CD3 molecules, present both in the stroma and inside tumor cords ( Fig. 1 D) . An equivalent number of CD4 and CD8 positive cells were detected with a majority of CD8 lymphocytes inside the tumor cords. Nearly all of the infiltrating T lymphocytes expressed the TCR a/fl as recognized by ,BF1 (data not shown) while no TCRb 1-positive y/5 T lymphocytes could be detected. Immunochemical staining was performed with the Ep2 mAb detecting the expression of the high molecular weight melanomaassociated antigen on melanoma cells (C), and with an anti-CD3 mAb to demonstrate T cell infiltrates in the tumor (D). Staining was performed using the alkaline phosphatase anti-alkaline phosphatase complex method (30) . Representative fields of the tissue sections examined are shown.
Analysis of the inflammatory peritumoral skin also revealed the presence of a/fl T lymphocytes grouped in numerous perivascular foci or dispersed in the derma (data not shown).
Comparative analysis ofTCR V1f gene segment expression.
The expression of the 24 Vfl gene subfamilies was analyzed by bispecific PCR performed on the tumor as well as autologous PBL and healthy skin as controls. Quantification of the cDNA samples was performed using Cf-Cf amplifications to use the same amount of specific cDNA for VA-specific amplifications allowing more accurate comparisons of the V: signals. In the case of the healthy skin, little if any T lymphocytes could be identified immunohistologically (data not shown), and Cf-Cfl as well as Vf amplifications did not generate signals sufficient to be analyzed by the scanning procedure. Comparing the tumor and autologous PBL, the most striking difference was a 5.7-fold stronger signal for the Vfl 16 gene segment in the tumor (Fig. 2) . Additional less marked differences (less than twofold) were noted for different V: such as Vf4, Vf Relative Vol -w24 subfamily usage in the tumor and the autologous PBL was determined by quantitative PCR and expressed as percentage of the sum of the total V: signal obtained after scanning, as indicated in Methods. was strongly overexpressed in the tumor. The corresponding transcripts were sequenced to characterize further this potentially in situ expanded pool of Vf 16+ T lymphocytes. A series of control samples were studied in parallel including Vfl16+ cDNA from the patient's healthy skin, autologous PBL, and that from an unrelated healthy donor. Two additional Vfl were selected as controls, one (Vf4) moderately amplified and the other (Vfl 9) lower amplified in the tumor compared to PBL (Fig. 2) . To avoid PCR artifacts, sequences were obtained from at least two different sets of amplifications performed on two different cDNA from the same sample. Together, 137 in frame f chain transcripts were characterized. Their complete analysis is summarized in Table I , panel A. The most striking observation was the predominance of a unique cDNA clone in the tumor representing 84% (38:45) of the Vf16 in frame transcripts and encoding an LRDSWN amino acid junctional sequence (Table I) . Another clone accounted for 9% (4:45) of the sequences in the tumor. In contrast, Vf 16 f-transcripts from autologous control PBL did not occur more than two times reflecting a regular polyclonal distribution (Table I) . A similar distribution was found when sequencing Vfl 6 f transcripts from unrelated allogeneic PBL (data not shown). Note that the predominant clone with the LRDSWN amino acid junctional sequence, present in the tumor, was not identified among autologous PBL Vf 16 transcripts. No Vl16 transcript could be amplified and cloned from patient's healthy skin.
Analysis of the Vf4 in frame transcripts revealed that a unique cDNA clone, encoding a QTSVVV junctional sequence, represented 47% ( 14:30) of the Vf4 transcripts in the tumor but was not identified in autologous PBL. Another cDNA clone, encoding for an ENGRE junctional sequence, was found in 3:30 sequences (10%) in the tumor. The Vf4' cDNA clones from autologous PBL were polyclonal, in that none ofthe sequences examined occurred more than two times (Table I, panel A) . Analysis of the Vfll9 sequences revealed that 2 Voll9 clones occurred 5:18 and 3:18 times in the tumor whereas no sequences occurred more than two times in autologous PBL.
Sequencing Vf16, Vf4, and Vfl 9 cDNA from the inflammatory peritumoral skin. Histological examination of the inflammatory peritumoral skin has revealed signs of regression including lymphocyte infiltration, lack of normal junctional melanocytes, and fibrosis (data not shown). No melanoma cells were detectable with the Ep-2 mAb specific for the HMW-MAA (31, 32) suggesting that tumor cells had been eradicated from this area. Therefore, it was of interest to assess whether the clones identified in the tumor were also present in the inflammatory peritumoral skin. As shown in Table I , panel B, the LRDSWN predominant Vl16 cDNA clone represented 100% (28:28) of the Vfl 16 in frame transcripts studied in this area. Similarly, when looking at the Vf4 gene segment, the two clones sharing the QTSVVV and the ENGRE junctional regions could be identified in 26% and 16% of the transcripts studied, respectively. On the other hand, several Vf4' cDNA clones were present only in the inflammatory peritumoral skin and not in the tumor. One of them, sharing a SRTGM junctional sequence represented 26% (5:19) ofthe transcripts in the inflammatory skin, and was not found elsewhere. In contrast, Vl19 transcripts were different from those present in the tumor and were not found more than two times.
In Situ T Cell Clonality in Regressive Melanoma 1187 All PCR-generated Vf3 16, V,34, and V# l9-TCR fragments were cloned into SacII-EcoRV pBS-SK' vector and sequenced as indicated in Methods. The encoded amino acid sequences ofthe junctional regions of clones occuring more than two times are shown according to the one letter code.
Discussion
Regressive melanoma represents a privileged situation where the often abundant T lymphocytes closely apposed to regressing nests oftumor cells ( 15-18) may well display an efficient in vivo immune response. We have studied here a clinically and pathologically representative case where well recognized histological criteria of tumor regression ( 17, (26) (27) (28) were present (see Fig. 1, A and B) . Immunohistological analysis demonstrated the presence of numerous a/f3 T cells in the tumor. Since monoclonal antibodies directed against each of the distinct V region ofthe TCR are not yet available, analysis ofTCR transcripts represents an acceptable alternative to study the T cell repertoire. We have analyzed TCR f3 chain transcripts because, similar to immunoglobulin loci, allelic exclusion is known to operate efficiently at the RNA level for the TCR d locus with only one in frame transcript expressed by a given T cell (37) . Note that this may not be the case for the TCR a loci where two in frame transcripts have been shown to be frequently expressed (38) (39) (40) . The TCR Vj3 usage of TIL and controls was first evaluated by PCR using Vf subfamily specific oligonucleotides that have been experimentally validated in previous studies (35) . Vf-specific amplifications revealed one major difference between the tumor and the autologous PBL, namely, an overrepresentation of the V/3 16 gene segment. Sequences were then performed to analyze the V-D-J-C junctional regions ofthe Vf 16 transcripts.
The results showed that 84% of the V,316 transcripts analyzed in the tumor corresponded to the same cDNA clone while all were different in autologous PBL. Together, these data strongly support the view that clonal expansion of a V1316+ T cell occurred locally. Studying V34 transcripts, which were moderately amplified in the tumor, we observed that one cDNA clone represented almost 47% ofthe transcripts in the tumor while all transcripts in PBL were different. Analyzing Vf3 19 transcripts, which were less represented in the tumor (Fig. 2) , we found that two clones accounted for 28 and 17% of the transcripts while the distribution was polyclonal in PBL.
The approach used here, namely, V/3-specific amplifications, allowed us to select the Vo16 subfamily for subsequent sequence experiments and to identify a Vf3 16 clonal expansion in the tumor. Analysis of the control Vfls indicated that clonal expansion of other T cells had occurred locally: it shows that strictly quantitative analyses may be misleading and outlines the importance of sequence analysis in fine studies on T cell repertoire. However, such experiments are presently extremely tedious and it is clear that novel more rapid (automated) methods have to be developed to allow extensive characterization of the T cell repertoire in immunopathological situations.
A limited number of comparable studies have been performed directly in situ or on freshly isolated TIL using either Southern blot analysis of TCR # chain rearrangements (41 ) the Va7 gene segment in uveal primary melanoma with no preferential usage of any V: gene segments. However, without sequence analysis, one cannot conclude that in situ clonal T cell expansion is present. We have recently performed sequence analysis using anchored PCR in metastatic melanoma and did not observe preferential Va or V: gene segment usage (43) . In vitro studies have reported oligoclonality of IL-2expanded TIL in melanoma (44) (45) (46) . However, the relevance ofthe latter data is difficult to appreciate since cultures, particularly long term, may select T cell subpopulations poorly represented in vivo.
To our knowledge, the present observation based on sequence analysis ofTCR transcripts constitutes an original demonstration that clonally expanded T cell populations may be present at the tumor site in a human cancer. The fact that the same V316 and Vf4 clones were identified in the inflammatory peritumoral skin, where more advanced histological signs of regression were observed, strengthens both the technical validity and the biological relevance ofthese findings. The demonstration of in situ clonal T cell expansion strongly suggests that antigen driven selection occurs at the tumor site. The relationship between the regression phenomena and amplification of clonal T cells have to be confirmed by functional studies.
